Keck Hartman, MD
Infectious Disease · Wichita, KSNPI 1912902685
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.8% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Insmed, Inc. at 24.8% of the total. Reporting peaked in 2019 at $618 and has fallen 88.7% since, to $70 in 2025.
Across 73 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$405
- AbbVie$327
- Smith+Nephew$181
- Organogenesis Inc.$122
- Gilead$103
- Octapharma USA, Inc.$74
- plus $422 from 13 others
What the payments were for
- Consulting fees$211%
- Food & beverage$1,50292%
- Education$1127%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 17 | $405 |
| AbbVie(2 entities) | 23 | $327 |
| Smith+Nephew | 4 | $181 |
| Organogenesis Inc. | 1 | $122 |
| Gilead | 6 | $103 |
| Octapharma USA, Inc. | 1 | $74 |
| Ferring Pharmaceuticals Inc. | 1 | $59 |
| Pfizer | 2 | $58 |
| Melinta Therapeutics, LLC | 4 | $57 |
| ADMA Biomanufacturing LLC | 2 | $41 |
| Vyera Pharmaceuticals, LLC | 2 | $35 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $33 |
| Integra Lifesciences Corporation | 1 | $31 |
| Convatec Inc. | 2 | $31 |
| Viiv Healthcare Company | 1 | $21 |
| Hospira, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$123
- Grafix$123
- STRAVIX PL$123
- GRAFIX PL$123
- PuraPly$122
How this compares
$1,635 in reported general payments places this provider in the 80th percentile of 56 infectious disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Wichita
- Thomas MooreWichita$37K
- Maha AssiWichita$9K
- Margaret HaganWichita$4K
- Garret SeilerWichita$2K
- Jerry PeterieWichita$2K
- Shelley JonesWichita$2K
- Wissam El AtrouniKansas City$15K
- John FriedOverland Park$7K
- Marjorie WongskhaluangLeawood$5K
- Apoorv KalraOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.